InsidersTradesSigma
Track the Acarix AB stock price and the full directors' dealings record of the company, a publicly traded company based in Finland. Shares are quoted on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, Acarix AB has recorded 6 reports. Market capitalisation: €296.9m. The latest transaction was filed on 22 September 2025 (Purchase). Among the most active insiders: Aamir Mahmood. The full history is accessible without an account.
6
Insider Decl.
n/a
Thresholds
€77,965
6 ops.
Buy Volume
n/a
n/a
Sell Volume
27Σ signal
Fundamental score
Ranked 23,319 of 29,064 companies
30.5
score / 100
Value13
Quality48
FCF yld-13%
Earn yld-17%
EV/EBITDA·
ROE-86%
Gross mgn85%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 22 September 2025
Declarations6 total
150,000 shares@ €0.02710.0013% mcap100.0% of flowAktieISIN SE0009268717FI:A003S480-1
385,553 shares@ €0.02630.0033% mcap14.9% of flowAktieISIN SE0009268717FI:A003S110-1
588,753 shares@ €0.02470.0048% mcap21.4% of flowAktieISIN SE0009268717FI:A003H027-2
1,382,000 shares@ €0.02040.0093% mcap41.4% of flowAktieISIN SE0009268717FI:A003L497-2
751,549 shares@ €0.02010.0050% mcap22.3% of flowAktieISIN SE0009268717FI:A003M644-2
150,000 shares@ SEK 0.40100.0% of flowTeckningsoptionISIN SE0009268717FI:A001P458-1
6 of 6 declarations
关于 Acarix AB
Acarix AB 是一家专注于开发心血管疾病诊断解决方案的公司。该公司在斯德哥尔摩证券交易所上市，股票代码为 XSTO。